MoneyWorks4Me

Piramal Pharma informs about disclosure

10 Sep 2024 Evaluate
Piramal Pharma has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for East Bridge Capital Master Fund I & East Bridge Capital Master Fund.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1846.30
Dr. Reddys Labs. 1221.50
Cipla 1392.30
Lupin 2071.65
Zydus Lifesciences 1213.10
View more..